Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > Ultratech Announces Second Quarter 2007 Results

Ultratech, Inc. (NASDAQ:UTEK) today announced unaudited results for the three-month and six-month periods ended June 30, 2007.

Ultratech Announces Second Quarter 2007 Results

San Jose, CA | Posted on July 26th, 2007

For the second quarter of fiscal 2007, Ultratech reported net sales of $30.0 million compared to $26.0 million during the second quarter of 2006. Ultratech's net income for the second quarter of 2007 was $1.0 million or $0.04 per share (diluted) compared to a net loss of $1.2 million or $0.05 per share for the same quarter last year.

For the first six months of 2007, Ultratech reported net sales of $57.4 million compared to net sales of $61.0 million in the first six months of 2006. Ultratech reported a net loss of $2.2 million or $0.10 per share during the first half of 2007, compared to net income of $0.4 million or $0.02 per share (diluted) for the first half of 2006.

Arthur W. Zafiropoulo, Chairman and Chief Executive Officer stated, "The second quarter results represented a solid quarter of execution. We improved our bottom line as a result of our actions to reduce costs and improve operational efficiency."

"During the quarter, logic device manufacturers invested in laser processing for 65nm production and 45nm development as evidenced by the shipment of a LSA100 tool and taking another tool into revenue for the quarter. Our advanced packaging products drove the company's business predominately in the solder bump 300mm area," continued Zafiropoulo.

"Ultratech will continue to improve operational efficiency to reduce product costs," Zafiropoulo concluded.

At June 30, 2007, Ultratech had $130.4 million in cash, cash equivalents, short-term investments and long-term investments. Working capital was $120.7 million and stockholders' equity was $7.45 per share based on 23,298,477 total shares outstanding on June 30, 2007.

Conference Call Information

The conference call will be broadcast live over the Internet beginning at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time on Thursday, July 26, 2007. To listen to the call over the Internet or to obtain telephone dial-in information for the call, please go to Ultratech's web site at

If you are unable to attend the live conference call, a replay will be available on Ultratech's web site. If you do not have Internet access, a replay of the call will be available three hours after the conclusion of the call until 9:00 p.m. Pacific Time, July 28, 2007. You may access the telephone replay by dialing 888-203-1112 for domestic callers, 719-457-0820 for international callers and entering access code: 6656241.


About Ultratech, Inc.
Ultratech, Inc. (NASDAQGM:UTEK) designs, manufactures and markets photolithography and laser processing equipment. Founded in 1979, Ultratech is a market leader in gold and solder bump lithography, in addition to being a pioneer of laser processing. Its advanced-packaging lithography systems deliver strong cost-of-ownership, repeatability and throughput advantages, and are widely used worldwide in the fabrication of semiconductors and FPDs. Ultratech’s advanced laser processing technology enhances yields, while enabling a cost-effective transfer to 65-nm and below production, and is being integrated into the manufacturing lines of leading-edge semiconductor manufacturers.

Certain of the statements contained herein, which are not historical facts and which can generally be identified by words such as “anticipates,” “expects,” “intends,” “will,” “could,” “believes,” “estimates,” “continue,” and similar expressions, are forward-looking statements under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties, such as risks related to integration of Oraxion’s technology and products with our technology and products and market acceptance thereof; our dependence on new product introductions and market acceptance of new products and enhanced versions of our existing products; lengthy sales cycles, including the timing of system installations and acceptances; lengthy and costly development cycles for laser-processing and lithography technologies and applications; integration, development and associated expenses of the laser processing operation; delays, deferrals and cancellations of orders by customers; cyclicality in the semiconductor and nanotechnology industries; pricing pressures and product discounts; high degree of industry competition; intellectual property matters; expiration of licensing arrangements, and the resulting adverse impact on our licensing revenues; changes to financial accounting standards; changes in pricing by us, our competitors or suppliers; customer concentration; international sales; timing of new product announcements and releases by us or our competitors; ability to volume produce systems and meet customer requirements; sole or limited sources of supply; ability and resulting costs to attract or retain sufficient personnel to achieve our targets for a particular period; dilutive effect of employee stock option grants on net income per share, which is largely dependent upon us achieving and maintaining profitability and the market price of our stock; mix of products sold; rapid technological change and the importance of timely product introductions; outcome of litigation; changes in accounting policies or interpretations of such policies; manufacturing variances and production levels; timing and degree of success of technologies licensed to outside parties; product concentration and lack of product revenue diversification; inventory obsolescence; asset impairment; effects of certain anti-takeover provisions; future acquisitions; volatility of stock price; foreign government regulations and restrictions and the exporting of sensitive technologies and jobs to certain countries; business interruptions due to natural disasters or utility failures; environmental regulations; and any adverse effects of terrorist attacks in the United States or elsewhere, or government responses thereto, or military actions in Iraq, Afghanistan and elsewhere, on the economy, in general, or on our business in particular. Such risks and uncertainties are described in Ultratech’s SEC reports including its Annual Report on Form 10-K filed for the year ended December 31, 2006 as amended and Quarterly Report on Form 10Q for the quarter ended March 31, 2007. Due to these and additional factors, the statements, historical results and percentage relationships set forth herein are not necessarily indicative of the results of operations for any future period. These forward-looking statements are based on management’s current beliefs and expectations, some or all of which may prove to be inaccurate, and which may change. We undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.

Jun. 30, Dec. 31,
(In thousands )         2007      




Current assets:
Cash, cash equivalents, and
short-term investments $96,441 $78,090
Accounts receivable 19,887 18,054
Inventories 37,265 40,988
Prepaid expenses and other
current assets         3,137       2,181
Total current assets 156,730 139,313
Long-term investments 33,997 48,328
Equipment and leasehold
improvements, net 19,105 20,326
Demonstration inventories, net 4,321 4,717
Other assets         2,109       3,366
Total assets         $216,262       $216,050
Current liabilities:
Notes payable $9,705 $6,974
Accounts payable 7,036 10,440
Deferred product and service income 6,244 2,950
Other current liabilities       13,030       13,998
Total current liabilities 36,015 34,362
Other liabilities 6,660


Stockholders' equity         173,587      


Total liabilities and stockholders' equity   $216,262       $216,050

(a) The balance sheet as of December 31, 2006 has been derived from the audited financial statements as of that date.

Three Months Ended Six Months Ended
Jun. 30, Jul. 1, Jun. 30, Jul. 1,
(In thousands, except per share amounts)   2007   2006 2007   2006

Total net sales(a)

$30,011 $26,043 $57,379 $60,987
Cost of sales:
Cost of products sold 14,413 11,821 28,873 30,937
Cost of services     2,422   2,411 4,530   4,582
Total cost of sales     16,835   14,232 33,403   35,519
Gross profit 13,176 11,811 23,976 25,468
Operating expenses:
Research, development, and
engineering 5,836 6,350 11,800 12,503
Selling, general, and
administrative     7,561   8,345 16,863   15,642
Operating income (loss) (221) (2,884) (4,687) (2,677)
Interest expense (138) (32) (471) (44)
Interest and other income, net   1,446   1,712 3,115   3,229
Income (loss) before tax 1,087 (1,204) (2,043) 508
Income taxes     67   (28)   182   102
Net income (loss)     $1,020   ($1,176)   ($2,225)   $406
Earnings per share - basic:
Net income (loss) $0.04 ($0.05) ($0.10) $0.02
Number of shares used in per share calculations - basic 23,368 23,927 23,395 23,879
Earnings per share - diluted:
Net income (loss) $0.04 ($0.05) ($0.10) $0.02
Number of shares used in per share calculations - diluted   23,467   23,927   23,395   25,031

(a)Systems Sales

$21,818 $17,972 $40,624 $44,845

Parts Sales

4,478 4,390 9,179 8,926

Service Sales

3,615 3,581 7,476 7,116

License Sales

    100   100   100   100
Total Sales     $30,011   $26,043   $57,379   $60,987

For more information, please click here

Ultratech, Inc., San Jose
Bruce Wright, 408-321-8835
Sr. Vice President, Finance/CFO
Laura Rebouché, 408-321-8835
Vice President of Investor Relations and
Corporate Communications

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Chip Technology

Gigantic ultrafast spin currents: Scientists from TU Wien (Vienna) are proposing a new method for creating extremely strong spin currents. They are essential for spintronics, a technology that could replace today's electronics May 25th, 2016

Diamonds closer to becoming ideal semiconductors: Researchers find new method for doping single crystals of diamond May 25th, 2016

Dartmouth team creates new method to control quantum systems May 24th, 2016

Attosecond physics: A switch for light-wave electronics May 24th, 2016


Scientists illuminate a hidden regulator in gene transcription: New super-resolution technique visualizes important role of short-lived enzyme clusters May 27th, 2016

Doubling down on Schrödinger's cat May 27th, 2016

Finding a new formula for concrete: Researchers look to bones and shells as blueprints for stronger, more durable concrete May 26th, 2016

Deep Space Industries and SFL selected to provide satellites for HawkEye 360’s Pathfinder mission: The privately-funded space-based global wireless signal monitoring system will be developed by Deep Space Industries and UTIAS Space Flight Laboratory May 26th, 2016


Scientists illuminate a hidden regulator in gene transcription: New super-resolution technique visualizes important role of short-lived enzyme clusters May 27th, 2016

Light can 'heal' defects in new solar cell materials: Defects in some new electronic materials can be removed by making ions move under illumination May 24th, 2016

More light on cancer: Scientists created nanoparticles to highlight cancer cells May 21st, 2016

Nanotubes are beacons in cancer-imaging technique: Rice University researchers use spectral triangulation to pinpoint location of tumors May 21st, 2016

Financial Reports

Nanometrics to Announce First Quarter Financial Results on April 26, 2016 April 5th, 2016

Nanometrics Achieves Record 3D-NAND Bookings Quarter: A Record 3D-NAND Bookings Quarter, both in Aggregate and for Each of Three Key Customers March 28th, 2016

Arrowhead to Webcast Fiscal 2015 Year End Results December 7th, 2015

Haydale Announce Year End Results November 3rd, 2015


Novel gene therapy shows potential for lung repair in asthma May 18th, 2016

Arrowhead Pharmaceuticals' Preclinical Candidate ARC-LPA Achieves 98% Knockdown and Long Duration of Effect after Subcutaneous Administration May 10th, 2016

Nanometrics Announces Upcoming Investor Events May 10th, 2016

Oxford Instruments Asylum Research and McGill University Announce the McGill AFM Summer School and Workshop, May 12-13, 2016 May 4th, 2016

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic